Skip to the page

Data / Drug companies / Methylprednisolone sodium succinate

Methylprednisolone sodium succinate: 14 companies and 45 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Methylprednisolone sodium succinate is listed in the FDA National Drug Code Directory by 14 companies, with 45 products in commercial distribution. 21 of the products (46.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, powder, for solution; injection, powder, lyophilized, for solution; injection, and the newest product started marketing on December 1, 2025.

The request: Get every company that lists methylprednisolone sodium succinate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
14
Products
45
Generic (ANDA) products
21 (46.7%)
Application numbers
7
Routes
Intravenous, Intramuscular, Intravascular
Brand names
Solu-Medrol, Solu-Medrol
openFDA record search
api.fda.gov

Companies that list methylprednisolone sodium succinate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Pharmacia & Upjohn Company LLC10injection, powder, for solutionNew drug applications (NDA)April 2, 1959
Hikma Pharmaceuticals USA Inc.5injection, powder, for solutionGeneric drugs (ANDA)January 15, 2024
Cardinal Health 107, LLC4injection, powder, for solutionNew drug applications (NDA)April 2, 1959
Dr. Reddy's Laboratories Inc.4injectionGeneric drugs (ANDA)March 24, 2022
Eugia US LLC4injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 15, 2015
Fresenius Kabi USA, LLC3injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 30, 2004
Medical Purchasing Solutions, LLC3injection, powder, for solutionNew drug applications (NDA)April 2, 1959
Remedyrepack Inc.3injection, powder, for solution; injectionGeneric drugs (ANDA)May 27, 2025
Civica, Inc.2injection, powder, for solutionGeneric drugs (ANDA)December 1, 2025
Henry Schein, Inc.2injection, powder, for solutionNew drug applications (NDA)January 12, 2022
ProPharma Distribution2injection, powder, for solutionNew drug applications (NDA)April 2, 1959
A-S Medication Solutions1injection, powder, for solutionNew drug applications (NDA)April 2, 1959
HF Acquisition Co LLC, DBA HealthFirst1injectionGeneric drugs (ANDA)March 24, 2022
Sportpharm LLC1injection, powder, for solutionNew drug applications (NDA)April 2, 1959

Dosage forms

Dosage formProductsShare
Injection, powder, for solution3271.1%
Injection, powder, lyophilized, for solution715.6%
Injection613.3%

Marketing categories

Marketing categoryProductsShare
New drug applications (NDA)2453.3%
Generic drugs (ANDA)2146.7%

Pharmacologic classes

ClassProducts
Corticosteroid45

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.